Journal Mobile Options
Table of Contents
Vol. 64, No. 3, 2010
Issue release date: September 2010
Eur Neurol 2010;64:148–155
(DOI:10.1159/000317011)

Kana versus Kanji in Amyotrophic Lateral Sclerosis: A Clinicoradiological Study of Writing Errors

Ichikawa H. · Hieda S. · Ohno H. · Ohnaka Y. · Shimizu Y. · Nakajima M. · Kawamura M.
Department of Neurology, Showa University School of Medicine, Tokyo, Japan

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

The frequency of writing errors in samples from 14 patients with amyotrophic lateral sclerosis without manifest aphasia were compared with clinical background and indices from X-ray computed tomography, including the Evans’ index (EI) and the cella media index (CMI). The inferior horn index (IHI) was measured as the maximal width of the short axis of the bilateral inferior horn of the lateral ventricles/the maximum transverse distance between the two internal laminae. Overt dementia and disinhibitive behavioral changes were significantly associated with frequency of total errors (p = 0.0280) and kanji errors (p = 0.0025). Significant associations were found for the EI with kana errors (p = 0.0481) and for the IHI with kanji errors (p = 0.0052). Preferential involvement of kana and kanji may reflect involvement of language-related areas in the frontotemporal lobes with frontal lobe or temporal lobe predominance.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. The Lund and Manchester groups: Clinical and neuropathological criteria for fronto-temporal dementia. J Neurol Neurosurg Psychiatry 1994;57:416–418.
  2. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, Freedman M, Kertesz A, Robert PH, Albert M, Boone K, Miller BL, Cummings J, Benson DF: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546–1554.
  3. Snowden JS, Neary D, Mann DMA: Fronto-Temporal Lobar Degeneration: Fronto-Temporal Dementia. Progressive Aphasia, Semantic Dementia. Clinical Neurology and Neurosurgery Monographs. New York, Churchill Livingstone, 1996.
  4. Okamoto K, Hirai S, Yamazaki T, Sun X, Nakazato Y: New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett 1991;129:233–236.
  5. Jackson M, Lennox G, Lowe J: Motor neuron disease-inclusion dementia. Neurodegeneration 1996;5:339–350.
  6. Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B: Are amyotrophic lateral sclerosis patients cognitively normal? Neurology 2003;60:1094–1097.
  7. Lomen-Hoerth C: Characterization of amyotrophic lateral sclerosis and frontotemporal dementia. Dement Geriatr Cogn Disord 2004;17:337–341.
  8. Strong M, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, Bruijn L, Ince P, Figlewicz D: Consensus criteria for the diagnosis of frontotemporal cognitive and behavioral syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009;10:131–146.
  9. Neumann M, Sampathu DM, Kwong LK, Traux AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, Lee VM: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130–133.
  10. Snowden J, Neary D, Mann D: Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol 2007;114:31–38.
  11. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T: TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602–611.
  12. Geser F, Martinez-Lage M, Robinson J, Uryu K, Neuman M, Brandmeir NJ, Xie SX, Kwong LK, Elman L, McCluskey L, Clark CM, Malunda J, Miller BL, Zimmerman EA, Qian J, Van Deerlin V, Grossman M, Lee VM, Trojanowski JQ: Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Ann Neurol 2009;66:180–189.

    External Resources

  13. Geser F, Martinez-Lage M, Kwong LK, Lee VMY: Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases. J Neurol 2009;256:1205–1214.
  14. Caselli RJ, Windebank AJ, Petersen RC, Komori T, Parisi JE, Okazaki H, Kokmen E, Iverson R, Dinapoli RP, Graff-Radford NR, Stein SD: Rapidly progressive aphasic dementia and motor neuron disease. Ann Neurol 1993;33:200–207.
  15. Rakowicz W, Hodges JR: Dementia and aphasia in motor neuron disease: an under-recognized association? J Neurol Neurosurg Psychiatry 1998;65:881–889.
  16. Tsuchiya K, Ozawa E, Fukushima J, Yasui H, Kondo H, Nakano I, Ikeda K: Rapidly progressive aphasia and motor neuron disease: a clinical, radiological, and pathological study of an autopsy case with circumscribed lobar atrophy. Acta Neuropathol 2000;99:81–87.
  17. Bak TH, O’Donovan DG, Xuereb JH, Boniface S, Hodges JR: Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neuron disease-dementia-aphasia syndrome. Brain 2001;124:103–120.
  18. Hyodo T, Ikeda M, Ueno S, Komori K, Hokoishi K, Fukuhara R, Tanabe H: A case of motor neuron disease with progressive aphasia and dementia. Brain Nerve 2002;54:713–718.

    External Resources

  19. Catani M, Piccirilli M, Geloso MC, Cherubini A, Finali G, Pelliccioli G, Senin U, Mecocci P: Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity. Dement Geriatr Cogn Disord 2004;17:21–28.
  20. Takayasu N, Ito K, Kondo M, Muranishi M, Nagakae Y, Nakagawa M: A case of amyotrophic lateral sclerosis presented as motor aphasia in its early stage. Brain Nerve 2006;58:709–713.

    External Resources

  21. da Rocha AJ, Valério BCO, Buainain RO, Ferraz ME, da Silva, Maria Jr ACM, Andrade VP, Lancellotti LP: Motor neuron disease associated with non-fluent rapidly progressive aphasia: case report and review of literature. Eur J Neurol 2007;14:971–975.
  22. Iroi A, Okuma Y, Fukae J, Fujishima K, Goto K, Mizuno Y: Amyotrophic lateral sclerosis presented with alexia of kanji and word meaning aphasia. Brain Nerve 2002;54:903–907.

    External Resources

  23. Kim SH, Seo AW, Go AM, Sun MK, Chin J, Jeong JH, Na DK: Semantic dementia combined with motor neuron disease. J Clin Neurol Sci 2009;16:1683–1685.

    External Resources

  24. Ferror I, Roig C, Espino A, Peiro G, Guiu M: Dementia of frontal lobe type and motor neuron disease. J Neurol Neurosurg Psychiatry 1991;54:932–934.
  25. Bak T, Hodges J: The effects of motor neuron disease on language: further evidence. Brain Lang 2004;89:354–361.
  26. Ichikawa H, Takahashi N, Hieda S, Ohno H, Kawamura M: Agraphia in bulbar-onset amyotrophic lateral sclerosis: not merely a consequence of dementia or aphasia. Behav Neurol 2008;20:91–99.
  27. Strong MJ, Grace GM, Orange JB, Leeper HA, Menon RS, Aere C: A prospective study of cognitive impairment in ALS. Neurology 1999;53:1665–1670.
  28. Kanzaki M, Sato M, Ogawa G, Miyamoto N, Motoyoshi K, Kamakura K, Takeda K: A case of dementia with motor neuron disease associated with agraphia: the omission of kana letters. Clin Neurol 2004;44:673–676.
  29. Iwata M: Kanji versus kana: neuropsychological correlates of the Japanese writing system. Trends Neurosci 1984;7:290–293.
  30. Kawamura M, Hirayama K, Hasegawa K, Takahashi N, Yamaura A: Alexia with agraphia of kanji (Japanese morphograms). J Neurol Neurosurg Psychiatry 1987;50:1125–1129.
  31. Soma Y, Yamadori A, Murata S, Imanaga H: Lexical agraphia in the Japanese language. Brain 1989;112:1549–1561.
  32. Yokota T, Ishiai S, Furukawa T, Tsukagoshi H: Pure agraphia of kanji due to thrombosis of the Labbe vein. J Neurol Neurosurg Psychiatry 1990;53:335–338.
  33. Sakurai Y, Matsumura K, Iwatsubo T, Momose T: Frontal pure agraphia for kanji or kana: dissociation between morphology and phonology. Neurology 1997;49:946–952.
  34. Sakurai Y: Varieties of alexia from fusiform, posterior inferior temporal and posterior occipital gyrus lesions. Behav Neurol 2004;15:35–50.
  35. World Federation of Neurology Research Group on Motor Neuron Diseases, El Escorial revised: Revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotroph Lateral Scler 2000;1:293–299.
  36. Evans WA: An encephalographic ratio for estimating ventricular enlargement and cerebral atrophy. Arch Neurol Psychiatry 1942;47:931–937.

    External Resources

  37. Adam P, Fabre N, Guell A, Bessoles G, Roulleau J, Bès A: Cortical atrophy in Parkinson disease: correlation between clinical and CT findings with special emphasis on prefrontal atrophy. AJNR 1983;4:442–445.
  38. Frisoni GB, Geroldi C, Beltramello A, Bianchetti A, Bienetti G, Bordia G, DeCarli C, Laakso MP, Soinnen H, Testa C, Zanetti O, Trabucchi M: Radial width of the temporal horn: sensitive measure in Alzheimer disease. AJNR 200;23:35–47.
  39. Satoh M, Takeda K, Kuzuhara S: Agraphia in intellectually normal Japanese patients with ALS: omission of kana letters. J Neurol 2009;256:1455–1460.
  40. Davis RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH: The pathological basis of semantic dementia. Brain 2005;128:1984–1995.
  41. Sakurai Y, Tsuchiya K, Oda T, Hori K, Tominaga I, Akiyama H, Bando M, Haga C, Iwata M, Mannen T: Ubiquitin-positive frontotemporal lobar degeneration presenting with progressive Gogi (word-meaning) aphasia. A neuropsychological, radiological and pathological evaluation of Japanese semantic patient. J Neurol Sci 2006;250:3–9.
  42. Tanaka Y, Yamadori A, Murata S: Selective kana agraphia: a case report. Cortex 1987;23:679–684.
  43. Kawamura M, Hirayama K, Yamamoto H: Different interhemispheric transfer of kanji and kana writing evidenced by a case with left unilateral agraphia without apraxia. Brain 1989;112:1011–1018.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50